Paradoxically, in some COVID-19 patients, the signs of hypercoagulability go together with apparent hypocoagulability detected by a prolonged prothrombin time, reduced clot growth rate in the thrombodynamics assay, and prolonged clotting time in TEG. Here, F2 is linked to COVID-19.